Skip to main content

2022 Rheumatology Year in Review (1-6-2023)

Dr. Jack Cush reviews the best of 2022 in Rheumatology - highlights on new drug indications, breakthrough lupus therapies, new biosimilars and the multivitamin letdown.

  1. FDA Regulatory Approvals & Indications
  2. Advancing Lupus treatments
  3. New Guidelines
  4. Dermatology Drug Hot Spot
  5. Attack of the Biosimilars
  6. Multivitamin Letdown
  7. New PMR/GCA Therapies
  8. Telemedicine
  9. FDA Safety Issues
  10. Waiting for RA

For more on these topics, read the full article here

Join The Discussion

Saurav Suman

| Jan 08, 2023 9:05 pm

I am very fortunate to be trained by Dr. Lightfoot. My training would have been never the same without him. He was unarguably the most humble and the most intelligent doctor that I knew.

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

The author has received compensation as an advisor or consultant on this subject